Literature DB >> 2244021

Radiosensitivity testing of primary cervical carcinoma: evaluation of intra- and inter-tumour heterogeneity.

S E Davidson1, C M West, S A Roberts, J H Hendry, R D Hunter.   

Abstract

Biopsies from 89 patients with cervical carcinoma were studied using a clonogenic assay to obtain values for the surviving fraction at 2 Gy (SF2). Heterogeneity in intrinsic radiosensitivity was investigated by independently processing multiple biopsies from 18 tumors. No significant differences between intra-tumour SF2 values were demonstrated (p = 0.30). The results have shown that intra-tumour heterogeneity is not a limitation to radiosensitivity testing using the Courtenay-Mills assay. A wide range of values (0.13-0.97) for SF2 was obtained with a mean value of 0.47 +/- 0.18 (+/- 1 S.D., CV = 38%) for 52 squamous cell carcinomas and 0.59 +/- 0.27 for four adenocarcinomas. There were statistically significant differences between the individual tumours (p less than 0.001). From the analysis-of-variance of all the SF2 results it appears to be the surviving fractions below about 0.40 and those above about 0.7 which show significant differences in radiosensitivity between pairs of tumours (p = 0.05). Also 36% of the values of SF2 show significant differences from the mean SF2 of all tumours. The storage of tumour cell suspensions in liquid nitrogen improved the colony-forming efficiency (CFE) but it did not alter the radiosensitivity.

Entities:  

Mesh:

Year:  1990        PMID: 2244021     DOI: 10.1016/0167-8140(90)90115-d

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  14 in total

1.  The intrinsic radiosensitivity and sublethal damage repair capacity of five cervical carcinoma cell lines tested with the 96-well-plate assay.

Authors:  V Rantanen; S Grénman; J Kulmala; R Grénman
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

2.  Temporal analysis of intratumoral metabolic heterogeneity characterized by textural features in cervical cancer.

Authors:  Fei Yang; Maria A Thomas; Farrokh Dehdashti; Perry W Grigsby
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-01-23       Impact factor: 9.236

3.  Prediction of radiotherapy response of cervical carcinoma through measurement of proliferation rate.

Authors:  B S Bolger; R P Symonds; P D Stanton; A B MacLean; R Burnett; P Kelly; T G Cooke
Journal:  Br J Cancer       Date:  1996-10       Impact factor: 7.640

4.  Fibroblast growth in the soft agar clonogenic assay for cervix cancer radiosensitivity.

Authors:  B Stausbøl-Grøn; H Havsteen; J Overgaard
Journal:  Br J Cancer       Date:  1998-08       Impact factor: 7.640

5.  In vitro radiosensitivity of tumour cells and fibroblasts derived from head and neck carcinomas: mutual relationship and correlation with clinical data.

Authors:  B Stausbøl-Grøn; S M Bentzen; K E Jørgensen; O S Nielsen; T Bundgaard; J Overgaard
Journal:  Br J Cancer       Date:  1999-03       Impact factor: 7.640

6.  The in vitro radiosensitivity of human head and neck cancers.

Authors:  T Björk-Eriksson; C M West; E Karlsson; N J Slevin; S E Davidson; R D James; C Mercke
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640

7.  The independence of intrinsic radiosensitivity as a prognostic factor for patient response to radiotherapy of carcinoma of the cervix.

Authors:  C M West; S E Davidson; S A Roberts; R D Hunter
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

8.  Intrinsic radiosensitivity and prediction of patient response to radiotherapy for carcinoma of the cervix.

Authors:  C M West; S E Davidson; S A Roberts; R D Hunter
Journal:  Br J Cancer       Date:  1993-10       Impact factor: 7.640

9.  Relationship between clonogenic radiosensitivity, radiation-induced apoptosis and DNA damage/repair in human colon cancer cells.

Authors:  A L Dunne; M E Price; C Mothersill; S R McKeown; T Robson; D G Hirst
Journal:  Br J Cancer       Date:  2003-12-15       Impact factor: 7.640

Review 10.  High dose rate versus low dose rate intracavity brachytherapy for locally advanced uterine cervix cancer.

Authors:  Ruifeng Liu; XiaoHu Wang; Jin Hui Tian; KeHu Yang; Jun Wang; Lei Jiang; Xiang Yong Hao
Journal:  Cochrane Database Syst Rev       Date:  2014-10-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.